Rosacea is a chronic skin condition that can cause persistent redness, flushing, and sensitivity—especially across the cheeks, nose, and forehead. While topical therapies, oral antibiotics, and laser treatments remain mainstays of care, a newer option is gaining attention: microdosed botulinum toxin, also known as microbotox.
Traditionally known for its cosmetic use in softening wrinkles, botulinum toxin is now showing promising results in reducing facial redness and vascular reactivity in rosacea patients. When injected superficially into the dermis in very small doses, microbotox appears to calm inflammation and reduce excessive vasodilation, leading to visibly clearer skin.
How Microbotox Differs from Traditional Botox:
Unlike standard Botox injections that relax facial muscles to treat wrinkles, microbotox targets the skin’s oil glands, vasculature, and neurogenic inflammation. This means it can improve skin tone, reduce redness, and even help with enlarged pores and excess oil—without freezing facial expressions.
What Microbotox Can Address:
Persistent facial flushing and redness due to rosacea
Enlarged pores and sebaceous (oily) skin
Residual redness unresponsive to topicals or laser
Sensitive skin that cannot tolerate harsh rosacea treatments
At Foxhall Dermatology, we offer microbotox for select rosacea patients who are seeking a more comprehensive approach to managing their symptoms. Especially in cases where traditional therapies fall short, microbotox offers a safe, non-invasive alternative that’s quickly gaining support in dermatology literature.
While still considered off-label, early clinical results have been promising and the patient feedback has been overwhelmingly positive. We’re proud to stay at the forefront of innovation in rosacea care, offering patients personalized solutions that deliver real results.
Keywords: microbotox, botulinum toxin rosacea, facial redness treatment, rosacea dermatologist, Botox DC, non-surgical rosacea therapy
